← back to search

Haineng Xu

Wenzhou Medical University · CN
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Cancer research, Medicine, Colonoscopy, Reversion, RAD51, and Olaparib.
h-index
citations
1,040
works
8
NIH funding
primary concept
email

Recent publications

A computer-aided diagnosis system using white-light endoscopy for the prediction of conventional adenoma with high grade dysplasia
Digestive and Liver Disease 2022cited by 5position: middledoi
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Nature Communications 2020cited by 364position: middledoi
Artificial intelligence assisted standard white light endoscopy accurately characters early colorectal cancer: a multicenter diagnostic study
medRxiv 2020cited by 1position: middledoi
Setting Standards to Promote Artificial Intelligence in Colon Mass Endoscopic Sampling
medRxiv 2019cited by 2position: middledoi
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
Nature Communications 2018cited by 290position: middledoi
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
Nature Communications 2018cited by 153position: middledoi
Circulating Glioma Cells Exhibit Stem Cell-like Properties
Cancer Research 2018cited by 110position: middledoi
The Traditional Chinese Medicine Baicalein Potently Inhibits Gastric Cancer Cells
Journal of Cancer 2016cited by 115position: lastdoi
Altered β1,6‐GlcNAc branched <i>N</i>‐glycans impair TGF‐β‐mediated Epithelial‐to‐Mesenchymal Transition through Smad signalling pathway in human lung cancer
Journal of Cellular and Molecular Medicine 2014cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tianrun Liu · Sun Yat-sen University4 papers (2016–2018)Yi Fan · Shandong University3 papers (2018–2018)Menggui Huang · Cleveland Clinic Lerner College of Medicine3 papers (2018–2018)Donald M. O’Rourke · Parker Institute for Cancer Immunotherapy3 papers (2018–2018)Zhenfeng Zhang · Southern University of Science and Technology3 papers (2018–2018)Yanqing Gong · Guangzhou University of Chinese Medicine3 papers (2018–2018) · 2 papers (2019–2022)Yongxiu Zhang · Zhejiang Provincial People's Hospital2 papers (2019–2022) · 2 papers (2019–2022)Steven Brem · Translational Therapeutics (United States)2 papers (2018–2018) · 2 papers (2019–2022)Yonggao Mou · Sun Yat-sen University2 papers (2018–2018)Zhenqiang He · Sun Yat-sen University2 papers (2018–2018)Sijun Meng · Xiamen University2 papers (2019–2022)Yulong He · China Aerodynamics Research and Development Center2 papers (2019–2022) · 2 papers (2019–2022)Siqi Wu · Henan University2 papers (2019–2022) · 2 papers (2019–2022)Zhaofang Han · Xiamen University2 papers (2019–2022)Lin Zhang · Simon Fraser University2 papers (2018–2018)